| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 01/30/2013 | EP2550021A2 Methods of increasing efficiency of vector penetration of target tissue |
| 01/30/2013 | EP2550011A1 Use of pcsk9 as a vaccine for lowering cholesterol |
| 01/30/2013 | EP2550009A1 Dendritic cell inhibitory proteins from ticks |
| 01/30/2013 | EP2550008A2 Novel use of erythroid differentiation regulator 1 as an agent for treating cancer |
| 01/30/2013 | CN1835968B Compositions and methods for increasing bone mineralization |
| 01/30/2013 | CN102906264A Treatment of interferon regulatory factor 8 (irf8) related diseases by inhibition of natural antisense transcript to irf8 |
| 01/30/2013 | CN102899343A Gene vector system, its preparation and application |
| 01/30/2013 | CN102899327A Antiviral small nucleic acid and temperature-sensitive type gel preparation and application thereof |
| 01/30/2013 | CN102899325A Small interfering RNA for TRAPPC4 gene target point, and uses thereof |
| 01/30/2013 | CN102899293A Mesenchymal stem cells genetically modified with angiopoietin 1 gene and construction method and application thereof |
| 01/30/2013 | CN102898528A Calreticulin-soluble programmed death receptor 1 fusion protein, and preparation method and purpose thereof |
| 01/30/2013 | CN102898524A Human-mouse chimeric antibody of anti-human tumor necrosis factor related apoptosis-inducing ligand receptor DR5, preparation method and uses thereof |
| 01/30/2013 | CN102898508A Polypeptide for enclosing TGF-beta acceptor or IL-10 acceptor, pharmaceutical composition and application |
| 01/30/2013 | CN102895677A Novel multivalent carrier vaccine for shrimp and application thereof |
| 01/30/2013 | CN102895676A New application of P53 gene |
| 01/30/2013 | CN102895675A HIV-1 (Human Immunodeficiency Virus-1)-targeted specific siRNA (small interfering Ribonucleic Acid) biological nanoparticle and preparation and application thereof |
| 01/30/2013 | CN102895674A Preparation method of chitosan-5'ppp-NS1shRNA nanocomposite |
| 01/30/2013 | CN102895673A Treatment of eye disorders |
| 01/30/2013 | CN102895672A Composition for treating cancers and use thereof |
| 01/30/2013 | CN102895671A Application of microRNA to prevention and / or treatment of heart disease |
| 01/30/2013 | CN102895668A Method of delivering a protein into a cell |
| 01/30/2013 | CN102895659A Composite vaccine for Alzheimer's disease prevention and treatment, and preparation method thereof |
| 01/30/2013 | CN102895652A Method for promoting osteoblast differentiation by using Runx2 and Osterix and application thereof |
| 01/30/2013 | CN102895190A Liposome preparation and preparation method and application thereof |
| 01/30/2013 | CN102335189B Medicament composition containing antisense polynucleotide targeting miR-214 |
| 01/30/2013 | CN102260701B Chicken defensin 9 gene expression vector and preparation method and use thereof |
| 01/30/2013 | CN101353671B Preparation and use of recombinant virus vector gene A3G |
| 01/29/2013 | US8362231 RNA interference mediating small RNA molecules |
| 01/29/2013 | US8362084 Histone deacetylases, and uses related thereto |
| 01/29/2013 | US8361987 DNA vaccines encoding heat shock proteins |
| 01/29/2013 | US8361982 Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell |
| 01/29/2013 | US8361981 Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides |
| 01/29/2013 | US8361978 Use of herpes vectors for tumor therapy |
| 01/29/2013 | US8361977 Compositions and methods for modulation of SMN2 splicing |
| 01/29/2013 | US8361787 Method for expression of small RNA molecules within a cell |
| 01/29/2013 | US8361482 Recombinant BCG tuberculosis vaccine designed to elicit immune responses to mycobacterium tuberculosis in all physiological stages of infection and disease |
| 01/29/2013 | US8361466 Tweak receptor |
| 01/29/2013 | US8361457 Duplexed parvovirus vectors |
| 01/29/2013 | CA2522645C New monoclonal antibody capable of binding integrin alpha10beta1 |
| 01/29/2013 | CA2522081C Recombinant influenza viruses holding a mutation in a transmembrane protein gene |
| 01/29/2013 | CA2469310C Plasmid mediated supplementation for treating chronically ill subjects |
| 01/29/2013 | CA2431891C Mutations in neuronal gene sodium-channel alpha 1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
| 01/29/2013 | CA2413353C Intervertebral disc |
| 01/29/2013 | CA2325574C Porcine adenovirus type 3 genome |
| 01/29/2013 | CA2322160C Vaccines, immunotherapeutics and methods for using the same |
| 01/29/2013 | CA2258485C Ribonuclease resistant rna preparation and utilization |
| 01/24/2013 | WO2013013165A2 Use of lna compounds for therapeutic inhibition of mir-21 in systemic lupus erythematosus |
| 01/24/2013 | WO2013012921A2 Nucleic acid aptamers |
| 01/24/2013 | WO2013012875A2 Bacterial rnas as vaccine adjuvants |
| 01/24/2013 | WO2013012835A2 Sirna useful in the treatment of flavivirus infection |
| 01/24/2013 | WO2013012811A2 Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, non-amyloidogenic polymerized proteins and peptides |
| 01/24/2013 | WO2013012806A2 Protection of cells from alu-rna-induced degenereation and inhibitors for protecting cells |
| 01/24/2013 | WO2013010406A1 Rna body and the uses thereof |
| 01/24/2013 | WO2012166875A9 Modulating innate immune cell activity by lunasin and selected cytokines |
| 01/24/2013 | US20130024956 Antibodies to cd40 |
| 01/24/2013 | US20130022999 Protein fragment complementation assays for the detection of biological or drug interactions |
| 01/24/2013 | US20130022680 Modalities for the treatment of degenerative diseases of the retina |
| 01/24/2013 | US20130022620 Assays and methods pertaining to pre-amyloid intermediates |
| 01/24/2013 | US20130022613 Wise/sost nucleic acid sequences and amino acid sequences |
| 01/24/2013 | US20130022538 Aptamer-mrna conjugates for targeted protein or peptide expression and methods for their use |
| 01/24/2013 | CA2842034A1 Protection of cells from alu-rna-induced degenereation and inhibitors for protecting cells |
| 01/23/2013 | EP2547768A1 Modified u7 snrnas for treatment of neuromuscular diseases |
| 01/23/2013 | EP2547368A2 Methods and compositions for the treatment of cancer |
| 01/23/2013 | EP2547367A1 System for improved delivery of gene modulating compounds |
| 01/23/2013 | EP2547353A2 Cancer treatment with recombinant vector |
| 01/23/2013 | CN1972958B Method of using adenoviral vectors to induce an immune response |
| 01/23/2013 | CN102888426A Minicircle gene vector and its preparation method and use |
| 01/23/2013 | CN102888422A DNA (Deoxyribose Nucleic Acid) vaccine vector based on B2L gene of contagious pustular dermatitis virus and preparation method and application thereof |
| 01/23/2013 | CN102888405A Paragonimus westermani adult miRNA (micro ribonucleic acid) and application thereof |
| 01/23/2013 | CN102888404A Sirna conjugate and preparation method thereof |
| 01/23/2013 | CN102888403A Application of micro ribonucleic acid (miRNA)-539 and miRNA-539antisense nucleotide, and medicinal composition for miRNA-539 antisense nucleotide |
| 01/23/2013 | CN102888401A Inhibitor for inducing pluripotent stem cells, and inducing method and application thereof |
| 01/23/2013 | CN102887953A Anti-abeta antibodies and their use |
| 01/23/2013 | CN102887951A Tuberculosis peptide Ag85B199-207 specific TCR and recombinant retroviral vector and use thereof |
| 01/23/2013 | CN102886052A Long lasting drug formulations |
| 01/23/2013 | CN102886051A Application of Klotho adeno-associated virus to preparation of medicine for treating hypertensive heart disease of spontaneous hypertensive rat (SHR) |
| 01/23/2013 | CN102886050A Application of miRNA-489 and medicinal composition |
| 01/23/2013 | CN102886049A Nanobiomaterial, its preparation method and nucleic acid compound |
| 01/23/2013 | CN102885776A Nanoparticle with simulated outer cell membrane structure as well as preparation method and application thereof |
| 01/23/2013 | CN102389575B Genetic engineering oral DNA vaccine and preparation method and application |
| 01/23/2013 | CN102226186B Activated Bax gene for treating malignant tumor by taking adenovirus as carrier |
| 01/23/2013 | CN102181446B siRNA capability of preventing influenza virus as well as expression vector and pharmaceutical composition of siRNA |
| 01/23/2013 | CN102181407B Recombinant adenovirus and dendritic cell modified by recombinant adenovirus and application of recombinant adenovirus and dendritic cell |
| 01/23/2013 | CN102002105B Gene, expression vector, expression method, expression cell and application of human papilloma virus (HPV) 16 E7E6 fusion protein |
| 01/23/2013 | CN101829330B Calcium phosphate composite nanoparticle carrying genes as well as preparation method and application thereof |
| 01/22/2013 | US8357670 Oligomeric compounds for the modulation of HIF-1A expression |
| 01/22/2013 | US8357669 Method of treatment for lymphedema comprising administering a polynucleotide encoding VEGF-D |
| 01/22/2013 | US8357668 Compositions and methods for promoting wound healing and tissue regeneration |
| 01/22/2013 | US8357666 Reprogramming a cell by inducing a pluripotent gene through RNA interference |
| 01/22/2013 | US8357665 Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response |
| 01/22/2013 | US8357664 Antisense antiviral compound and method for treating influenza viral infection |
| 01/22/2013 | US8357363 Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom |
| 01/22/2013 | CA2622074C Rapid production of high titer virus |
| 01/22/2013 | CA2506798C Compositions and systems for the regulation of genes |
| 01/22/2013 | CA2448607C Colloidal metal compositions and methods |
| 01/22/2013 | CA2441663C Viral vectors and their use in therapeutic methods |
| 01/22/2013 | CA2375619C Equine granulocyte-macrophage colony-stimulating factor (gm-csf) |
| 01/22/2013 | CA2337574C Hematopoietic stem cell expansion enhancing factor and method of use |
| 01/17/2013 | WO2013010176A2 Pharmacophores for amyloid fibers involved in alzheimer's disease |
| 01/17/2013 | WO2013010069A1 Modified viral structural protein with antiviral activity |